Regentatlantic Capital LLC Novartis Ag Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Novartis Ag stock. As of the latest transaction made, Regentatlantic Capital LLC holds 12,956 shares of NVS stock, worth $1.35 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

12,956

Previous 15,850 18.26%

Holding current value

$1.35 Million

Previous $1.34 Million 26.49%

% of portfolio

0.03%

Previous 0.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $215,921 - $252,530	-2,894 Reduced 18.26%	12,956 $985,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $102,663 - $119,531	-1,275 Reduced 7.45%	15,850 $1.34 Million
Q1 2022 May 02, 2022	SELL	$80.11 - $90.62 $114,877 - $129,949	-1,434 Reduced 7.73%	17,125 $1.5 Million
Q4 2021 Jan 27, 2022	SELL	$79.7 - $88.13 $46,226 - $51,115	-580 Reduced 3.03%	18,559 $1.62 Million
Q3 2021 Nov 15, 2021	SELL	$81.78 - $95.14 $123,487 - $143,661	-1,510 Reduced 7.31%	19,139 $1.57 Million
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $209,519 - $231,420	-2,458 Reduced 10.64%	20,649 $1.88 Million
Q1 2021 Apr 29, 2021	BUY	$83.5 - $98.47 $1,419 - $1,673	17 Added 0.07%	23,107 $1.98 Million
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $358,497 - $433,622	-4,592 Reduced 16.59%	23,090 $2.18 Million
Q3 2020 Oct 13, 2020	SELL	$82.14 - $91.0 $862,305 - $955,318	-10,498 Reduced 27.5%	27,682 $2.41 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $221,505 - $249,340	-2,737 Reduced 6.69%	38,180 $3.34 Million
Q1 2020 May 14, 2020	SELL	$70.67 - $99.01 $298,086 - $417,624	-4,218 Reduced 9.35%	40,917 $3.37 Million
Q4 2019 Feb 04, 2020	BUY	$84.35 - $95.37 $86,121 - $97,372	1,021 Added 2.31%	45,135 $4.27 Million
Q3 2019 Oct 22, 2019	SELL	$85.54 - $94.26 $13,857 - $15,270	-162 Reduced 0.37%	44,114 $3.83 Million
Q2 2019 Jul 23, 2019	BUY	$75.4 - $92.8 $1.36 Million - $1.68 Million	18,071 Added 68.96%	44,276 $4.04 Million
Q1 2019 May 03, 2019	BUY	$75.32 - $86.15 $148,079 - $169,370	1,966 Added 8.11%	26,205 $2.52 Million
Q4 2018 Jan 30, 2019	SELL	$73.66 - $82.02 $5,008 - $5,577	-68 Reduced 0.28%	24,239 $2.08 Million
Q3 2018 Oct 30, 2018	BUY	$66.94 - $77.43 $85,281 - $98,645	1,274 Added 5.53%	24,307 $2.09 Million
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $87,758 - $99,182	-1,352 Reduced 5.54%	23,033 $1.74 Million
Q1 2018 Apr 23, 2018	SELL	$70.39 - $84.15 $71,657 - $85,664	-1,018 Reduced 4.01%	24,385 $1.97 Million
Q4 2017 Jan 23, 2018	SELL	$72.33 - $77.64 $8,824 - $9,472	-122 Reduced 0.48%	25,403 $2.13 Million
Q3 2017 Oct 25, 2017	BUY	$74.14 - $77.27 $1.89 Million - $1.97 Million	25,525	25,525 $2.19 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Novartis Ag Transaction History